Buenas Prácticas en la Administración de Rituximab: Revisión Integradora de la Literatura

Autor: Rodrigues, Carmelita Almeida, Lima, Maria Theresa Camilo de, De Domenico, Edvane Birelo Lopes

Publikováno v: Revista Brasileira de Cancerologia; Vol. 68 No. 3 (2022): July/Aug./Sept.; e-112194
Revista Brasileira de Cancerologia; Vol. 68 Núm. 3 (2022): jul./ago./sept; e-112194
Revista Brasileira de Cancerologia; v. 68 n. 3 (2022): jul./ago./set.; e-112194
Revista Brasileira de Cancerologia
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA

Introduction: Rituximab is a mouse/human chimeric monoclonal antibody, widely used in the therapeutic setting of various diagnoses, due to its different administration, management and adverse effects protocols; its use requires attention by the healt

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::ee1ed0d585f357fccce123ac1b055ac6
https://rbc.inca.gov.br/index.php/revista/article/view/2194